Why the study?
Does activation of fatty acid metabolism with fat feeding or a PPARalpha agonist exacerbate LV dysfunction in a rat infarct model of heart failure?
Population
Rats with infarct-induced heart failure (n = 38) or sham-operated rats (n = 10)
Comparison
High-fat diet or PPARalpha agonist fenofibrate… vs Untreated infarcted rats and sham-operated rats
Design
Preclinical
Follow-up
12 weeks
Authors
Loading...
Fatty acid activation does not worsen post-infarct LV dysfunction in rats; leaves open relevance to human HF.
Does activation of fatty acid metabolism with fat feeding or a PPARalpha agonist exacerbate LV dysfunction in a rat infarct model of heart failure?
In a rat infarct model of heart failure, upregulation of the fatty acid metabolic pathway via high-fat diet or fenofibrate did not worsen LV dysfunction or dilation.
Morgan et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: